Data protection Impressum

Life sciences

In a significant step toward future pandemic preparedness, researchers at the University of Bern have uncovered a new mechanism by which coronaviruses manipulate human cells to replicate, offering a promising target for broad-spectrum antiviral therapies.

University of Bern researchers identify promising new strategy against coronaviruses

1 April 2025

A team of researchers from the University of Bern and Japan’s RIKEN Institute has achieved a major breakthrough in sustainable chemistry by developing a novel method to synthesize organic molecules using sodium and iron—two abundant, non-toxic metals. The innovation could pave the way for more environmentally friendly production of pharmaceuticals and fine chemicals.

The University of Bern and RIKEN develop greener chemistry for pharmaceutical production

25 March 2025

Bern-based medtech company machineMD has announced a strategic partnership with Topcon Healthcare. The collaboration aims to integrate machineMD’s neurodiagnostic technology with Topcon’s digital health platform, paving the way for earlier and more precise detection of neurological diseases within a connected care ecosystem.

Neurodiagnostics specialist machineMD secures strategic investment from Topcon Healthcare

24 March 2025

The Foundation for Technological Innovation (FIT) has awarded funding to promising Western Switzerland start-ups PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.

Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT

17 March 2025

A research team at .NeuroRestore (EPFL/CHUV/UNIL) has developed an innovative rehabilitation approach that combines robotic-assisted therapy with spinal cord stimulation, offering new hope for individuals with spinal cord injuries.

.NeuroRestore’s breakthrough in robotics and spinal stimulation restores mobility after paralysis

17 March 2025

Lausanne-based Limula has introduced LimONE, a fully automated cell therapy manufacturing platform designed to streamline production, reduce costs, and improve accessibility for patients. The company expects to deliver the first units by 2028.

Limula unveils LimONE, a breakthrough in automated cell therapy manufacturing

10 March 2025

Geneva-based Neurosoft Bioelectronics has set a new benchmark in neurotechnology with its high-resolution, stretchable brain interface for epilepsy monitoring. The EPFL spin-off successfully tested its device on two human patients, paving the way for broader clinical applications.

Neurosoft Bioelectronics advances brain interface technology for epilepsy and tinnitus

5 March 2025

Bernese start-up ATANIS Biotech has won Phase 2 of the FARE Innovation Award Diagnostic Challenge, securing USD 2 million to advance its FAST-PASE allergy test.

ATANIS Biotech secures USD 2 million for its FAST-PASE allergy test

3 March 2025

Vaud-based biopharma Oculis has successfully completed an oversubscribed USD 100 million offering, further strengthening its pipeline of innovative ophthalmic and neuro-ophthalmic treatments.

Oculis secures USD 100 million to advance its neuroprotective treatment pipeline

17 February 2025

The University Hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva, and the Wyss Center are joining forces to establish Switzerland’s first artificial intelligence health hub at Campus Biotech, set to open in the second half of 2025.

An artificial intelligence health hub is set to open at Campus Biotech

17 February 2025

1 2 3 4 5 6 7 8 … 43